Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126456101 | 12645610 | 1 | I | 2007 | 20160803 | 20160811 | 20160811 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201608002618 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160810 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126456101 | 12645610 | 1 | PS | Insulin Human | INSULIN HUMAN | 1 | Unknown | 40 IU, EACH MORNING | U | U | 18780 | 40 | IU | QD | |||||
| 126456101 | 12645610 | 2 | SS | Insulin Human | INSULIN HUMAN | 1 | Unknown | UNK, EACH EVENING | U | U | 18780 | QD | |||||||
| 126456101 | 12645610 | 3 | SS | HUMULIN N | INSULIN HUMAN | 1 | Unknown | 40 IU, EACH MORNING | U | U | 0 | 40 | IU | QD | |||||
| 126456101 | 12645610 | 4 | SS | HUMULIN N | INSULIN HUMAN | 1 | Unknown | UNK, EACH EVENING | U | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126456101 | 12645610 | 1 | Product used for unknown indication |
| 126456101 | 12645610 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126456101 | 12645610 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126456101 | 12645610 | Administration site necrosis | |
| 126456101 | 12645610 | Blood glucose increased | |
| 126456101 | 12645610 | Fibromyalgia | |
| 126456101 | 12645610 | Headache | |
| 126456101 | 12645610 | Hepatic steatosis | |
| 126456101 | 12645610 | Injection site bruising | |
| 126456101 | 12645610 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |